Immunotherapy is here to stay
Drug Discovery World
JULY 25, 2023
DDW’s Megan Thomas spoke with Frédéric Triebel , the French immunologist/oncologist who is best known for his 1990 discovery of the LAG-3 immune control mechanism. Triebel shares insights from his career, expands on his experience with the company he founded, Immutep, and comments on the future of immuno-oncology (I-O). Background Lymphocyte-activation gene 3, or LAG-3, is a gene that provides the genetic information to make a cell surface molecule with biologic effects on T-cell function.
Let's personalize your content